Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair

Overview of attention for article published in Journal of Hematology & Oncology, June 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 5 X users
patent: 14 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 32 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

IMMUNOSTEP S.L., 21 Jun 2017

An article published this year in “JOURNAL OF HEMATOLOGY

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.